QTLs in Region (GRCm39)
1301267 | Bcmd2_m | B cell maturation defect 2 (mouse) | | | Not determined | | 4 | 133154678 | 150789451 | Mouse |
4142139 | Adip12_m | adiposity 12 (mouse) | | | Not determined | | 4 | 124621281 | 156860686 | Mouse |
10047132 | Albq19_m | albuminuria QTL 19 (mouse) | | | Not determined | | 4 | 112824389 | 146824389 | Mouse |
1301525 | Lmb1_m | lupus in MRL and B6 F2 cross (mouse) | | | Not determined | | 4 | 124264957 | 150676858 | Mouse |
14746982 | Manh56_m | mandible shape 56 (mouse) | | | | | 4 | 117815917 | 151815917 | Mouse |
25314312 | Syncl2_m | synaptonemal complex length 2 (mouse) | | | | | 4 | 65718237 | 146584457 | Mouse |
1300743 | Skull6_m | skull morphology 6 (mouse) | | | Not determined | | 4 | 111009051 | 145009280 | Mouse |
1301382 | Arvm2_m | autoimmune renal vasculitis 2 (mouse) | | | Not determined | | 4 | 107791564 | 141791756 | Mouse |
1302149 | Tlsr2_m | thymic lymphoma suppressor region 2 (mouse) | | | Not determined | | 4 | 124264957 | 142230960 | Mouse |
1300874 | Gasa2_m | gastritis type A susceptibility locus 2 (mouse) | | | Not determined | | 4 | 133010494 | 156860686 | Mouse |
27226757 | Femd1_m | femur midshaft diameter 1, 5 week (mouse) | | | | | 4 | 123993793 | 144326570 | Mouse |
1300621 | Tpnr1_m | thermal pain response 1 (mouse) | | | Not determined | | 4 | 125230872 | 156860686 | Mouse |
11567249 | Elorr3_m | ethanol induced loss of righting response 3 (mouse) | | | | | 4 | 3722677 | 156268235 | Mouse |
4142493 | Femwf13_m | femur work to failure 13 (mouse) | | | Not determined | | | 116154678 | 150154782 | Mouse |
1301815 | Sles2_m | systemic lupus erythmatosus suppressor 2 (mouse) | | | Not determined | | 4 | 94957579 | 150676858 | Mouse |
1300917 | Gasa1_m | gastritis type A susceptibility locus 1 (mouse) | | | Not determined | | 4 | 124055093 | 142438020 | Mouse |
1300537 | Ap3q_m | alcohol preference 3 QTL (mouse) | | | Not determined | | 4 | 134654451 | 156860686 | Mouse |
1301823 | Bmd7_m | bone mineral density 7 (mouse) | | | Not determined | | 4 | 88982069 | 151654550 | Mouse |
10412210 | Cypr6_m | cytokine production 6 (mouse) | | | Not determined | | 4 | 120617848 | 154617995 | Mouse |
1302078 | Sluc21_m | susceptibility to lung cancer 21 (mouse) | | | Not determined | | 4 | 117401141 | 151401275 | Mouse |
10045620 | Heal22_m | wound healing/regeneration 22 (mouse) | | | Not determined | | 4 | 125230872 | 156860686 | Mouse |
4142481 | Gct1_m | granulosa cell tumorigenesis 1 (mouse) | | | Not determined | | 4 | 127784226 | 156860686 | Mouse |
13503348 | Bntq18_m | bone traits QTL 18 (mouse) | | | | | 4 | 120617848 | 154617995 | Mouse |
13208562 | Wght7_m | weight 7 (mouse) | | | | | 4 | 90888237 | 148084457 | Mouse |
1300780 | Cocrb16_m | cocaine related behavior 16 (mouse) | | | Not determined | | 4 | 138943725 | 156860686 | Mouse |
4141184 | Tb2r1_m | TGF-beta2 responsiveness 1 (mouse) | | | Not determined | | | 137674005 | 150676858 | Mouse |
4142077 | Ignpq2_m | IgA nephropathy QTL 2 (mouse) | | | Not determined | | 4 | 133676733 | 156860686 | Mouse |
1301584 | Lrdg2_m | light induced retinal degeneration 2 (mouse) | | | Not determined | | 4 | 129465811 | 151654550 | Mouse |
4141180 | Ssic1_m | susceptibility to small intestinal cancer 1 (mouse) | | | Not determined | | | 120674005 | 154674151 | Mouse |
1302102 | Bis1_m | beta-carboline-induced seizures 1 (mouse) | | | Not determined | | 4 | 119864433 | 153864536 | Mouse |
10043996 | Gct5_m | granulosa cell tumorigenesis 5 (mouse) | | | Not determined | | 4 | 127784226 | 156860686 | Mouse |
26884445 | Sklq7_m | skull length QTL 7, 10 week (mouse) | | | | | 4 | 68018237 | 150884457 | Mouse |
10043985 | Stheal12_m | soft tissue heal 12 (mouse) | | | Not determined | | 4 | 121342649 | 155342753 | Mouse |
1357534 | Cinda3_m | cytokine induced activation 3 (mouse) | | | Not determined | | 4 | 137617848 | 142289472 | Mouse |
1301982 | Pltiq1_m | phospholipid transfer protein inducibility QTL 1 (mouse) | | | Not determined | | 4 | 124621281 | 156860686 | Mouse |
26884437 | Sklq13_m | skull length QTL 13, 16 week (mouse) | | | | | 4 | 57700000 | 155684457 | Mouse |
1300803 | Sluc6_m | susceptibility to lung cancer 6 (mouse) | | | Not determined | | 4 | 120674005 | 154674151 | Mouse |
4142061 | Chlq16_m | circulating hormone level QTL 16 (mouse) | | | Not determined | | 4 | 121342649 | 155342753 | Mouse |
1300933 | Cdcs9_m | cytokine deficiency colitis susceptibility 9 (mouse) | | | Not determined | | 4 | 125230872 | 156860686 | Mouse |
1300553 | Athsq1_m | atherosclerosis susceptibility QTL 1 (mouse) | | | Not determined | | 4 | 137617848 | 151654550 | Mouse |
1301452 | Elsgp1_m | elevated serum gp70 1 (mouse) | | | Not determined | | 4 | 121342649 | 155342753 | Mouse |
1301964 | Bw8q2_m | body weight at 8 weeks QTL 2 (mouse) | | | Not determined | | 4 | 119864433 | 153864536 | Mouse |
10755520 | Rbc1_m | red blood cell count 1 (mouse) | | | | | 4 | 108477692 | 142477692 | Mouse |
10755521 | Hct1_m | hematocrit 1 (mouse) | | | | | 4 | 108477692 | 142477692 | Mouse |
10755522 | Hgb1_m | hemoglobin 1 (mouse) | | | | | 4 | 108477692 | 142477692 | Mouse |
1301108 | Scon2_m | sucrose consumption 2 (mouse) | | | Not determined | | 4 | 134654451 | 156860686 | Mouse |
1300858 | Tafat_m | tally ho associated mesenteric fat pad weight (mouse) | | | Not determined | | 4 | 124621281 | 156860686 | Mouse |
10755531 | Lymph3_m | lymphocyte differential 3 (mouse) | | | | | 4 | 124553483 | 156860686 | Mouse |
11533916 | Mts1_m | mammary tumor susceptibility 1 (mouse) | | | | | 4 | 125289325 | 156860686 | Mouse |
1300839 | Dyscalc2_m | dystrophic cardiac calcinosis 2 (mouse) | | | Not determined | | 4 | 111009051 | 145009280 | Mouse |
4141001 | Tgq17_m | triglyceride QTL 17 (mouse) | | | Not determined | | | 112523489 | 146523489 | Mouse |
15039385 | Mvlq3_m | macrovesicular liver lesion QTL 3 (mouse) | | | | | 4 | 112182386 | 146182386 | Mouse |